AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Novo Nordisk stock tumbled Friday after its weight-loss drug Wegovy landed on Medicare's next list of drugs to face price negotiations.

Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...